Trademark Overview
On Thursday, April 24, 2025, a trademark application was filed for BOLDACCELERATOR with the United States Patent and Trademark Office. The USPTO has given the BOLDACCELERATOR trademark a serial number of 99154143. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, April 24, 2025. This trademark is owned by Co-Lab Global, Inc.. The BOLDACCELERATOR trademark is filed in the Advertising, Business and Retail Services and Computer & Software Services & Scientific Services categories with the following description:
Providing independent review of clinical trials for business purposes; Business consulting and management in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes; Recruitment advertisement services, namely, posting of clinical trial notices for the purpose of recruiting patients for participation in clinical trials for the testing of drugs; Business consulting, management, and planning services in the field of clinical trials; Business management consulting and advisory services for the clinical trials industry; Business management consultation in the field of clinical trials; Business assistance, advisory and consulting services in the field of clinical trials; Business management and consultation in the field of clinical trials; Business consultation in the field of clinical trials; Business consulting services in the field of clinical trials; Project management for others for business purpose...
Consulting services for others in the field of design, planning, and implementation project management of clinical trials; Providing medical and scientific research information in the field of clinical trials; Designing and developing websites in the field of clinical trials for others; Providing scientific information in the field of clinical trials; Providing scientific research information in the field of clinical trials; Providing information about medical and scientific research; Technical writing in the field of clinical trials